CT-derived brain volumes and plasma p-Tau217 for risk stratification of amyloid positivity in early-stage Alzheimer’s disease
Abstract Background Early detection of amyloid-β (Aβ) pathology is critical for timely intervention in Alzheimer’s disease (AD). While Aβ positron emission tomography (PET) and cerebrospinal fluid (CSF) biomarkers are accurate, their high cost and limited accessibility hinder routine use. We develop...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-10-01
|
| Schriftenreihe: | Alzheimer’s Research & Therapy |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13195-025-01870-z |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
